Cited by 4,642Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchGlobal Health and Epidemiology

Global estimates of diabetes prevalence for 2013 and projections for 2035

Open access
Guariguata, L., Whiting, D.R., Hambleton, I., Beagley, J., Linnenkamp, U., Shaw, J.E.·2014·Diabetes Research and Clinical Practice

Abstract

Introduction Diabetes is a serious and increasing global health burden and estimates of prevalence are essential for appropriate allocation of resources and monitoring of trends.Methods We conducted a literature search of studies reporting the age-specific prevalence for diabetes and used the Analytic Hierarchy Process to systematically select studies to generate estimates for 219 countries and territories. Estimates for countries without available source data were modelled from pooled estimates of countries that were similar in regard to geography, ethnicity, and economic development. Logistic regression was applied to generate smoothed age-specific prevalence estimates for adults 20-79 years which were then applied to population estimates for 2013 and 2035.Results A total of 744 data sources were considered and 174 included, representing 130 countries. In 2013, 382 million people had diabetes; this number is expected to rise to 592 million by 2035. Most people with diabetes live in low- and middle-income countries and these will experience the greatest increase in cases of diabetes over the next 22 years.Conclusion The new estimates of diabetes in adults confirm the large burden of diabetes, especially in developing countries. Estimates will be updated annually including the most recent, high-quality data available.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.diabres.2013.11.002

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

11 of the 87 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Borissova AM, Shinkov A, Kovatcheva R. Prevalence of diabetes in Bulgaria and the significance of the risk factors: age, obesity and family history. Endocrinologia 2006;7(1):42-9.

Cited by

Sorted by citations

Authors
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E.
Affiliations
  • International Diabetes Federation (BE)
  • University of the West Indies (BB)
  • Baker Heart and Diabetes Institute (AU)
Corresponding author
Guariguata, L.
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
2014-02
Volume
103
Issue
2
Pages
137-149
ISSN
0168-8227 (ISSN-L)
OpenAlex
W2139923324
Cited by
4,642
References
87
Citations by year
2026: 79 · 2025: 146 · 2024: 251 · 2023: 272 · 2022: 364 · 2021: 455 · 2020: 465 · 2019: 518 · 2018: 500 · 2017: 581 · 2016: 477 · 2015: 339 · 2014: 178 · 2013: 11 · 2012: 2
FWCI
264.31
Type
journal article
Language
en
Open access
Locations
  • Diabetes Research and Clinical Practice (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eli Lilly and Company
  • Pfizer
  • Sanofi
  • Novo Nordisk
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Health Professions › Health Information Management › Global Health and Epidemiology
Keywords
diabetes prevalence, diabetes projections, age-specific prevalence, low- and middle-income countries, global health burden, population projections, analytic hierarchy process
MeSH terms
Developing Countries, Diabetes Mellitus, Forecasting, Health Resources, Humans, Global Health, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review